Numinus Wellness Inc - NUMIF stock
| OTC Tier: OTCQX International | Related ticker symbols: TSX: NUMI
Numinus Wellness Inc. (OTC: NUMIF, TSX: NUMI)is a Canadian-based mental health and wellness company that is focused on the research, development, and delivery of psychedelic-assisted psychotherapy. The company was founded in 2018 and is headquartered in Vancouver, British Columbia.
The company's symbol changed from LKYSF to NUMIF on 11/22/2021.
Numinus Wellness is licensed by Health Canada to conduct research on psilocybin and other psychedelic compounds. The company is also focused on developing safe and effective methods for delivering psychedelic therapies, and operates several clinics where patients can receive these treatments under the supervision of trained medical professionals.
In addition to its research and clinical work, Numinus Wellness is also involved in the production and distribution of natural health products, including medical cannabis. The company's goal is to provide people with new and innovative ways to improve their mental health and overall well-being.
Numinus Wellness is one of several companies that are working to develop psychedelic-assisted therapies, which have shown promising results in the treatment of various mental health conditions, including depression, anxiety, and addiction. As interest in these therapies grows, Numinus Wellness is well-positioned to play a leading role in this emerging field.
